aspirin and glp-1 PDF) Unexpected cardiovascular risks of glucagon‐like peptide‐1 receptor agonist co‐administration in individuals with obesity, with and without type 2 diabetes: A propensity score matched cohort study Current Perspectives on GLP-1 Agonists

A., Taher, I., Abubaker, J

Its losing mostly fat, preserving muscle, maintaining training, and setting yourself up for results that are easier to keep long term because no one starts this process hoping to lose weight in a way that leaves them feeling weaker, under fueled, and harder pressed to maintain the results later

However, in Northern Ireland, only those with type 2 diabetes who meet certain criteria can access the drugs on the NHS

Details can be found at: 10.3389/fendo.2025.1663787

While improvements in diet and physical activity might explain some of the overall improvement, they do not account for the differences observed between the active and placebo groups

If you eat 4,000 calories daily, no supplement creates the deficit needed for weight loss